New results announced at the International Congress on Alzheimer’s disease (ICAD) in Chicago indicate that a medical nutrition product (SouvenaidTM) may offer a new option in the management of people with mild Alzheimer’s disease.
More: continued here
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post
Best Deal Ads :





